Global Point of Care
The benefits of POC troponin testing on ED and laboratory efficiency, ED length of stay (LOS), and staff satisfaction were evaluated at Memorial Hospital Central*, a part of Memorial Health System in Colorado Springs, CO. At the time of the study, Memorial Hospital Central had a 68-bed ED with an annual census of 105,000 visits. Investigators implemented a serial POC troponin testing protocol at the bedside for patients presenting to the ED with chest, abdominal, or shoulder pain, and for whom a cardiac troponin test was indicated as part of the clinical workup.
To compare the impact of POC testing, investigators assessed:
Before POC testing, blood analysis for suspected ACS patients was performed by the central laboratory and included a cardiac marker panel (troponin, creatine kinase-MB [CK-MB], and myoglobin), a basic metabolic panel (BMP), and a complete blood count (CBC). This study evaluated the impact of moving to a single cardiac biomarker workflow using the i-STAT cTnI test from Abbott Point of Care.
**avg. LOS of 290 mins. pre-i-STAT implementation vs. 255 mins. post-i-STAT implementation | Although demonstrating a lower trend, the change did not reach statistical significance.
Introduction of POC troponin testing in the ED can help institutions reduce door-to-troponin result times and ED LOS. Establishing a multidisciplinary team that included leaders and clinicians from the central laboratory and the ED was key to the successful implementation of POC testing at Memorial Hospital Central. In addition, ED staff satisfaction with POC testing was high, supporting the benefits of POC testing on improved patient flow, quality of care, and employee productivity.
Point-of-care diagnostic tests put invaluable answers in the hands of doctors, clinicians, and caregivers when and where they’re needed most
*The results shown here are specific to this health care facility and may differ from those achieved by other institutions.
A Leader In Rapid Point-of-care Diagnostics.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.